We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.67%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$46.3B
AUM Growth
+$3.2B
Cap. Flow
+$2.34B
Cap. Flow %
5.06%
Top 10 Hldgs %
17.9%
Holding
3,541
New
248
Increased
1,836
Reduced
1,143
Closed
207

Top Buys

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$308M
2
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$188M
3
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$172M
4
PSA icon
Public Storage
PSA
+$47.9M
5
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$46.9M

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$53.7M
2
MCD icon
McDonald's
MCD
+$46.3M
3
SO icon
Southern Company
SO
+$33.8M
4
HEWJ icon
iShares Currency Hedged MSCI Japan ETF
HEWJ
+$26.3M
5
ETP
Energy Transfer Partners L.p.
ETP
+$24.9M

Sector Composition

Rank Sector Weight
1 Technology 9.28%
2 Healthcare 9.23%
3 Financials 8.81%
4 Industrials 6.85%
5 Communication Services 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DUC
3101
DELISTED
Duff & Phelps Utility & Corporate Bond Trust
DUC
$94K ﹤0.01%
10,240
-5,000
-33% -$46.2K
ESV
3102
DELISTED
Ensco Rowan plc
ESV
$94K ﹤0.01%
4,573
-17,029
-79% -$489K
CLMT icon
3103
Calumet Specialty Products
CLMT
$3.55B
$93K ﹤0.01%
21,965
-3,425
-13% -$13.7K
ALL icon
3104
CALL
Allstate
ALL
$70.5B
$92K ﹤0.01%
17,500
+6,000
+52% +$509K
IAF
3105
abrdn Australia Equity Fund
IAF
$127M
$92K ﹤0.01%
5,052
– –
AMGN icon
3106
CALL
Amgen
AMGN
$218B
$90K ﹤0.01%
10,600
-25,300
-70% -$4.12M
AAC
3107
DELISTED
AAC Holdings
AAC
$90K ﹤0.01%
12,960
-12,053
-48% -$86.1K
SWK icon
3108
CALL
Stanley Black & Decker
SWK
$15.5B
$89K ﹤0.01%
12,700
-600
-5% -$82.3K
TWX
3109
CALL
DELISTED
Time Warner Inc
TWX
$89K ﹤0.01%
74,300
+24,600
+49% +$2.44M
CELP
3110
DELISTED
Cypress Environmental Partners, L.P.
CELP
$88K ﹤0.01%
11,800
-1,800
-13% -$14.1K
JAZZ icon
3111
CALL
Jazz Pharmaceuticals
JAZZ
$16.8B
$86K ﹤0.01%
+12,100
New +$1.85M
ARRS
3112
CALL
DELISTED
ARRIS International plc Ordinary Shares
ARRS
$86K ﹤0.01%
+47,500
New +$1.3M
NG icon
3113
NovaGold Resources
NG
$2.99B
$85K ﹤0.01%
18,590
+8,318
+81% +$35.8K
VRN
3114
DELISTED
Veren
VRN
$85K ﹤0.01%
11,070
-1,097
-9% -$10.3K
LGCY
3115
DELISTED
Legacy Reserves Inc. Common Stock
LGCY
$83K ﹤0.01%
56,756
-7,041
-11% -$13.6K
EEM icon
3116
CALL
iShares MSCI Emerging Markets ETF
EEM
$29.2B
$82K ﹤0.01%
45,000
– –
ASNA
3117
DELISTED
Ascena Retail Group, Inc.
ASNA
$82K ﹤0.01%
1,908
+66
+4% +$3.81K
IRDM icon
3118
CALL
Iridium Communications
IRDM
$5.18B
$81K ﹤0.01%
292,200
+33,600
+13% +$351K
NNVC icon
3119
NanoViricides
NNVC
$35.4M
$81K ﹤0.01%
3,000
– –
NVAX icon
3120
Novavax
NVAX
$1.25B
$81K ﹤0.01%
3,519
+200
+6% +$3.92K
VOC icon
3121
VOC Energy
VOC
$51M
$81K ﹤0.01%
19,060
-5,539
-23% -$24.5K
ZNGA
3122
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$77K ﹤0.01%
21,120
-180
-0.8% -$591
SAND
3123
DELISTED
Sandstorm Gold
SAND
$76K ﹤0.01%
19,600
-2,600
-12% -$9.87K
WKHS icon
3124
Workhorse Group
WKHS
$36.3M
$76K ﹤0.01%
+7
New +$65.5K
PVLA
3125
Palvella Therapeutics
PVLA
$2.22B
$76K ﹤0.01%
188
– –
123 124
125
126 127

Similar funds

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
ECU
Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AA
Axiom Advisory San Diego, California $10.7B AUM 25.51% 1-Year Est. Return
SA
SpiderRock Advisors Wilimington, Delaware $6.29B AUM
WPL
Winder Pte Ltd Singapore $5.59B AUM 41.5% 1-Year Est. Return
ECU
Eisler Capital (US) New York $4.67B AUM 35.2% 1-Year Est. Return

Raymond James & Associates's Q2 2017 Portfolio in Review

As of Q2 2017, Raymond James & Associates held 3,541 positions worth $46.3B, up 7.4% from $43.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Raymond James & Associates deployed $2.34B of net new capital in Q2 2017, opening 248 new positions and adding to 1,836 existing holdings. Its largest new stake was DXC Technology: 324,843 shares worth $21.6M.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 9.6% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Novartis, an estimated $53.7M trimmed.

  • Raymond James & Associates's largest Q2 2017 buy was DXC Technology: 324,843 shares worth $21.6M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2017, an estimated $308M increase.
  • Raymond James & Associates's biggest Q2 2017 reduction was Novartis, cutting an estimated $53.7M.
  • Raymond James & Associates fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $24.9M.
  • Raymond James & Associates's ten largest holdings make up 18% of its $46.3B portfolio in Q2 2017.
  • Raymond James & Associates opened 248 new positions and closed 207 in Q2 2017.
  • Raymond James & Associates's portfolio value rose 7.4% quarter-over-quarter to $46.3B.

Based on Raymond James & Associates's 13F filing for Q2 2017, filed 14 Aug 2017.